Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 10,169,910 |
|
|||||
| News | - | ||||||
| Day High | 105.3791 | Low High |
|||||
| Day Low | 103.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.95 | 0.92% | 104.41 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 103.78 | 103.73 | 105.3791 | 105.06 | 103.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 96,453 | 10,169,910 | $ 104.87 | $ 1,066,473,409 | - | 96.36 - 119.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:26 | 40 | $ 105.05 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 266.22B | 2.53B | - | 59.28B | 14.52B | 5.73 | 18.34 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 101.91 | 105.3791 | 99.80 | 101.92 | 12,501,434 | 2.50 | 2.45% |
| 1 Month | 104.00 | 105.3791 | 99.80 | 102.27 | 8,252,831 | 0.41 | 0.39% |
| 3 Months | 109.18 | 109.67 | 99.14 | 103.54 | 7,109,218 | -4.77 | -4.37% |
| 6 Months | 112.75 | 115.61 | 99.14 | 106.53 | 7,334,874 | -8.34 | -7.4% |
| 1 Year | 109.81 | 119.65 | 96.36 | 108.32 | 7,686,312 | -5.40 | -4.92% |
| 3 Years | 81.14 | 119.65 | 70.89 | 88.37 | 10,316,053 | 23.27 | 28.68% |
| 5 Years | 79.30 | 119.65 | 65.25 | 85.29 | 10,233,569 | 25.11 | 31.66% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
